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Abstract
Background: Tuberculosis (TB) is a disease of poverty that contributes significantly to ill-health in developing
countries. Drug resistant TB is a major challenge to disease control. Early diagnosis and rapid determination of drug
sensitivity is of paramount importance in eradication of TB. Although automated liquid culture based methods are
available for rapid detection of drug resistance, the high cost of these tests prevent them from being used
routinely in low resource settings. This study compares two phenotypic methods, the manual Mycobacteria Growth
Indicator Tube (MGIT) and the Nitrate Reductase Assay (NRA) in liquid medium, with the agar proportion method
(APM), the gold standard for susceptibility testing of Mycobacterium tuberculosis.
Methodology: Fourteen day old M. tuberculosis strains (n=373) grown on solid media were used for drug
susceptibility testing by APM, NRA and the manual MGIT method. Rifampicin free and rifampicin incorporated (final
concentration, 1 μg/ml) media were inoculated with the recommended concentrations of mycobacterial
suspensions and incubated at 37°C in 5% CO2. In the APM, the proportion of colonies in the drug containing
medium was determined. In the NRA, the colour change in the medium was compared with a standard colour
series after day 6 and day 12 of incubation. Growth in the MGIT was detected using the manual MGIT reader from
day 2 onwards. The 2 methods were compared with the gold standard, APM to determine sensitivity and specificity
and agreement between the methods was calculated using kappa statistics.
Results: Thirty one (31) rifampicin resistant isolates were identified. When compared with the APM, the sensitivity
of detection of rifampicin resistance was 85% for the NRA and 93% for the manual MGIT and the specificity was
99% and 100% respectively. Both assays, NRA (κ=0.86) and manual MGIT method (κ= 0.94) were in excellent
agreement with the APM. The mean turnaround time for manual MGIT method and NRA were 08 days and 10 days
respectively.
Conclusion: The NRA in liquid medium and manual MGIT are useful alternatives to APM for drug susceptibility
testing of M. tuberculosis in low resource settings.
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Background
The population of Sri Lanka is about 20 million and it is
considered a low TB prevalence country in the Asian re-
gion. In Sri Lanka, the estimated incidence of all forms
of tuberculosis in 2009 was 66 per 100,000 population.
In 2009, 9643 new TB cases were notified and 5186
among them being sputum smear positive TB cases. The
notification rate of TB was slightly increased when com-
pared to the year 2008 [1]. The drug resistant rate in Sri
Lanka is also low. It is around 0.2% among new TB
patients and 18%–21% among re-treatment cases. The
HIV co-infection rate among TB patients is currently
estimated to be less than 0.1% [2].
Tuberculosis control activities in Sri Lanka operate
through the National Programme for Tuberculosis Con-
trol & Chest Diseases (NPTCCD) which is a decentralized
unit under the Ministry of Health. There are 26 chest
clinics in the 25 administrative districts of Sri Lanka and
the internationally recommended Directly Observed
Treatment Short course (DOTS) strategy is used for
treatment of TB patients throughout the island [1].
Multi Drug Resistant Tuberculosis (MDR-TB) is
defined as resistance to isoniazid and rifampicin, the two
most effective drugs among the currently used anti TB
drugs [3]. Rifampicin is the important drug especially in
the short-course treatment regimen. Significantly, rifam-
picin resistant isolates are also resistant to isoniazid, mak-
ing rifampicin resistance a useful marker of MDR-TB
[4,5]. Early and accurate diagnosis of MDR TB is very
important for prevention and control of the disease.
Currently several rapid and automated liquid culture
methods such as the BACTEC 460 radiometric system
and the MGIT 960 system for diagnosis of MDR-TB [6,7]
have been commercialized [3]. However, these methods
are beyond the reach of laboratories in most developing
countries including Sri Lanka, due to high cost and the
need for complex infrastructure facilities [8-11].
In Sri Lanka, drug susceptibility testing (DST) is
carried out using the conventional proportion method
on Lowenstein-Jensen (L-J) medium which requires a
minimum of 28 days. This significantly delays the detec-
tion of drug resistance and appropriate treatment. Estab-
lishing a rapid culture based method for identification of
rifampicin resistance is essential for control and preven-
tion of MDR-TB. Therefore the objective of this study
was to evaluate the suitability of the manual Mycobac-
teria Growth Indicator Tube and the nitrate reductase




Three hundred and seventy three (373) isolates of M.
tuberculosis cultured from suspected TB patients during
the period March 2008 to September 2010 were used for
the study. The reference strain, M. tuberculosis H37Rv
and a known rifampicin resistant isolate confirmed by
the National Tuberculosis Institute, Bangalore were used
as quality control strains.
Preparation of rifampicin solution
Rifampicin stock solution (10 mg/ml) was prepared by
dissolving 10 mg of rifampicin powder (Sigma, USA) in
1 ml dimethyl sulphoxide (Sigma, USA). Filter sterilized
aliquots of stock rifampicin solutions were kept at −70 °C
until use. A working solution (1mg/ml) was prepared by
diluting the stock solution with sterile double distilled
water and used only once [12].
Isolation of M. tuberculosis from clinical specimens
Sputum specimens were processed using the modified
Petroff ’s method and concentrated by centrifugation at
3500 g in a refrigerated (4°C) centrifuge for 15 minutes
[13]. Sediment was diluted in 1 ml sterile distilled
water. A small portion of the suspension was stained
with Ziehl-Neelsen (ZN) stain and examined micro-
scopically for the detection of acid fast bacilli [14].
Two slopes of L-J (Difco, US) (one containing parani-
trobenzoic acid to detect Mycobacterium other than
tuberculosis (MOTT) species) were inoculated with
100 μl of above bacterial suspension. The inoculated
culture media were incubated at 37°C in 5% CO2 until
growth was observed or discarded as negative after 8
weeks. Culture isolates were confirmed as M. tuberculosis
if they were slow growing, non-pigment producing,
reduced nitrate and did not grow in the presence of
paranitrobenzoic acid. Further, species confirmation
was carried out by PCR amplification of heat killed
bacterial DNA [15] using primers derived from IS
6110 insertion element of Mycobacterium genome,
pt18 (5'-GAA CCG TGA GGG CAT CGA GG-3') and




Agar proportion method (APM) remains the gold stand-
ard for culture based drug susceptibility testing for M.
tuberculosis. The proportion method was carried out on
Middlebrook 7H10 agar (Difco, US) plates as per CLSI
guidelines [12]. Fourteen day old, fresh M. tuberculosis
cultures grown on L-J medium were suspended in 7H9
broth medium to achieve a turbidity of McFarland No.1
standard. This suspension was further diluted (two fold
and four fold) and used for inoculating rifampicin incor-
porated (1 μg/ml) agar plates and rifampicin free control
agar plates. Colonies on each plate were counted on the
28th and 42nd day of inoculation, and the proportion of
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organisms growing in the presence of rifampicin was cal-
culated using the following equation [12].
No: of colonies on drug containing medium
No: of colonies on drug fee control medium
 100
(Strains that showed ≥ 1% were considered as resist-
ance to rifampicin)
Manual Mycobacterium Growth Indicator Tube (MGIT)
The MGIT (BD diagnostics, US) contains 4 ml of modi-
fied Middlebrook 7H9 broth with a fluorescence-
quenching-based oxygen sensor embedded on the bot-
tom of the tube. The level of fluorescence that the tube
emits corresponds to the amount of oxygen consumed
by organisms, which in turn is proportional to the num-
ber of bacteria present [17,18]. The rifampicin contain-
ing tubes (final rifampicin concentration of 1 μg/ml) were
inoculated with 500 μl of a 1:5 dilution of a McFarland
No: 0.5 bacterial suspension and rifampicin free control
tubes were inoculated with 500 μl of a 1:500 dilution of
McFarland No: 0.5 bacterial suspension as per manufac-
turer’s guidelines. The emission of fluorescence was mea-
sured using the manual MGIT reader from day 2 onwards.
If the drug free control tube gave positive reading and the
drug containing tube did not show a positive reading up
to 15 days of inoculation the test strain was read as
sensitive to rifampicin. The test was repeated when the
drug free control tube failed to give a reading in the
positive range within 13 days of inoculation. The presence
of Mycobacterium in the test and control tubes was
confirmed microscopically by ZN stain.
Nitrate Reductase Assay
The nitrate reductase assay is based on the ability of M.
tuberculosis to reduce nitrate to nitrite by the nitrate re-
ductase enzyme and in the present study, NRA in liquid
medium was evaluated as a drug susceptibility test
method [19]. Middlebrook 7H9 broth medium with 0.1%
sodium nitrate was used as the medium. The final con-
centration of rifampicin in the medium was 1 μg/ml.
Each drug containing medium was inoculated with 100 μl
of McFarland No: 1 bacterial suspension prepared
from 14 day old M. tuberculosis strains grown on L-J
medium. The control medium was inoculated with
100 μl of a 1:10 dilution of the same bacterial suspension
[20]. Two sets of the drug free and drug containing
media were inoculated per isolate. After 6 days, the first
set was examined for a colour change by sequentially
adding of Griess reagent (10 μl of 50% HCI, 20 μl of
0.2% sulfanilamide and 20 μl of 0.1% N-napthtylethylene-
diamine) to the culture medium. Readings were obtained
visually by comparing with the prescribed colour stan-
dards (Figure 1) [14]. Readings between +5 to +3 of the
standard colour series (Figure 1) were considered positive.
The drug free control medium was tested after 6 days and
if it was negative, the second set was tested at day 12. If
the drug free control gave a colour change within the
positive range of the standard color series and the drug
containing medium did not yield a colour change even
after 12 days of incubation the isolate was considered sen-
sitive to rifampicin (Figure 2). In order to prevent false
negative results (if the produced nitrite have further
reduced to nitric oxide), a small amount of powdered zinc
(Sigma, USA) was added to each negative tube [21] and
tested for generated nitrite in the medium by sequentially
adding of HCI, sulfanilamide and N-napthtylethylene-
diamine as described above. Development of a dark
pink colour indicated the absence of the M. tuberculosis
in the test medium. Bacterial contamination may cause
false positive results. Therefore, to ensure that the
media were free of contaminants the inoculated NRA
broths were streaked on blood agar plates to detect any
non-specific bacterial growth before testing for colour
changing.
+5 +4 +3 +2 +1 +/-
Positive colour range Negative colour range 
Figure 1 Standard colour series for nitrate reductase assay (WHO, laboratory services in tuberculosis control culture part iii). Colour
range from +5 to +3 was considered as positive.
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DNA sequencing
The rpoB gene mutations, of the rifampicin resistant iso-
lates, detected by any one of the phenotypic methods,
were identified by DNA sequencing (Macrogen –Korea).
Data analysis
The suitability of the manual MGIT and the NRA in
comparison with the APM was evaluated in terms of
sensitivity (the ability to detect true drug resistance),
specificity (the ability to detect true drug susceptibility),
positive likelihood ratio and negative likelihood ratio. A
positive likelihood ratio above 10 or a negative likelihood
ratio below 0.1 was considered to indicate excellent test-
performance, and ratios above 5 and below 0.2 were
considered to indicate adequate performance. The agree-
ment between the NRA results or the manual MGIT
results, and the APM were estimated by kappa statistics.
The kappa value(k), a measure of test reliability, was
interpreted as follows: <0.2, poor; 0.21 to 0.4, fair; 0.41
to 0.6, moderate; 0.61 to 0.8, good; ≥0.81, excellent [22].
The consumable costs per test were calculated in deter-
mining the cost for each test method.
Results
Thirty one rifampicin resistant isolates (resistant by
one of the 3 methods) were identified among the 373
M. tuberculosis strains isolated during the study period
March 2008 to September 2010. All 31 phenotypically
resistant strains showed point mutations in the rpoB
gene responsible for coding for rifampicin resistance
(data not shown – see Additional file 1).
Twenty seven strains out of 31 were detected as rifam-
picin resistant by the APM, the currently used gold
standard for conventional methods. MGIT and NRA
identified 26 isolates each. There were 3 discordant
results between the NRA and the APM and one discord-
ant result between the MGIT and the APM. Three iso-
lates that were detected as rifampicin resistant by NRA
were susceptible by the manual MGIT and APM.
Furthermore, one isolate that was rifampicin resistant by
the manual MGIT was susceptible by APM and NRA
(Table 1). Repeat testing of these 4 isolates provided the
same results.
The sensitivity and specificity of the NRA in 7H9
broth medium when compared with the APM were 85%
and 99% respectively (Table 2). Thus, there was a very
good agreement between NRA and APM for detection
of rifampicin resistance (κ= 0.86). An excellent agree-
ment was also observed between the manual MGIT and
APM (κ= 0.94) (Table 3) with 93% sensitivity and 100%
specificity. The average turnaround time for MGIT and
NRA in liquid medium was 08 days (mean) and 10 days
(mean) respectively.
Discussion
Rapid and accurate detection of drug resistance is a pre-
requisite for initiating effective anti-TB treatment. In Sri
Lanka, presently, DST for M. tuberculosis is carried out
S1 D S1 C S2 D S2 C
Figure 2 An example of a test result of an isolate tested using NRA. C-Rifampicin free control, D-Rifampicin containing medium, S1-
Rifampicin susceptible strain of M. tuberculosis, S2- Rifampicin resistant strain of M. tuberculosis.
Table 1 Pattern of Individual strains (n=31) showing
resistance to rifampicin with the DST methods used in
the study
Strain no (Lab No.) DST method/s that
confirmed rifampicin
resistance
C4, C6, C7, C8, C9, C10, C20, C73, C83,
C86, C88, C115, M60, M127, M15, C27,
C22 C23,C163, C254 C150, C135, C110
APM, MGIT and NRA
(n=23)
M9, M33 APM and MGIT
(n=2)




M46 , C25, M22 Only NRA
(n=3)
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only at the central reference laboratory, Welisara using
solid based DST method. Liquid culture based or mo-
lecular based DST methods for detection of drug resist-
ance are not yet available. Establishment of a more rapid
DST method would positively impact the management
of a patient harbouring a drug resistant strain. As rifam-
picin resistance is considered a surrogate maker of MDR
TB, WHO recommends performing DST at least for ri-
fampicin, especially in low resource settings [3].
In contrast to solid medium based DST methods,
NRA and MGIT use an indicator to detect growth in
the liquid medium, eliminating the need for visualization
of growth as colonies. Therefore, NRA in liquid medium
and MGIT methods are an attractive alternative to con-
ventional methods. In this study, a good agreement was
observed between APM and NRA in liquid medium or
manual MGIT in the detection of rifampicin resistance.
Similar results for detection of rifampicin resistance by
manual MGIT and NRA have been reported previously
[18,19,23,24].
The consumable cost per test for APM and NRA is
around US$ 4.00 and US$ 3.00 respectively. Compara-
tively, the manual MGIT is more expensive (~US$ 7.00).
However, both the NRA and the manual MGIT methods
can be initiated with low technical expertise and initial
cost. Additionally both methods are more rapid than the
APM as the results of susceptibility testing will be avail-
able in less than 2 weeks.
In the evaluation of the manual MGIT for identifica-
tion of rifampicin resistance, an in-house preparation of
rifampicin solution was used instead of the commercially
available rifampicin drug preparation kit (BD diagnos-
tics, US). The appropriate volume of rifampicin solution
was added to obtain a final concentration of 1 μg/ml of
drug in the 4 ml broth medium. The excellent agreement
between the MGIT and APM detecting rifampicin resist-
ance confirms the suitability of using in-house preparation
of drugs instead of commercially available drug kits that
increases the cost of the test. The manual MGIT reader
is a reliable and suitable instrument for use in low
resource countries as no housing is required and the
results can be read by placing the tube in the reading slot
(See additional file 2). The time spent to take a read-
ing is about 30 seconds. The cost of a MGIT reader
is around US$ 3000 and it is a once only investment.
Alternatively, in the absence of a manual MGIT reader a
simple ultra violet (UV) lamp (365 nm) may be used to
detect growth [25].
In the NRA, a standard colour series [14] was used to
interpret test results. In the case of intermediate results,
the test should be repeated for accurate interpretation.
In our series, 2 of the 373 tests required repeat testing.
The intermediate results in NRA may occur due to low
inoculum in the medium. Contamination of the test
medium can also lead to erroneous results as several
other bacteria can reduce nitrate to nitrite. Therefore, it
is important to ensure that there is no bacterial con-
tamination, prior to reporting results of the NRA. Per-
forming a purity test by sub culturing a blood agar
plate with a loopful of test medium will prevent report-
ing of false positive test results due to contaminating
bacterial flora.
Conclusion
In conclusion, both the NRA in liquid medium and the
manual MGIT agreed well with the APM in determin-
ation of rifampicin resistance. Introduction of these
methods for low resource settings will make the deter-
mination of rifampicin resistance faster and cost effect-
ive. As the need for sophisticated instruments and high
technical skills is minimal, the initial test establishment
cost will be low. Therefore, the NRA in liquid medium
and the manual MGIT are suitable alternatives to APM
that can be used to determine rifampicin resistance es-
pecially in low resource settings.
Table 2 Sensitivity, specificity, positive and negative likelihood ratio for NRA compared to APM (n=373)






Resistant (27) 23 4 85 98 0.15
Susceptible (346) 3 343 99
Table 3 Sensitivity, specificity, positive and negative likelihood ratio for the MGIT method compared to APM (n=373)






Resistant (27) 25 2 93 167 0.04
Susceptible (346) 1 345 100
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